mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.02 |
mRNA |
681640 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.02 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.02 |